Articles
6 June 2024
Advances in Sterilization Technologies for Overcoming Viral-Vector Manufacturing Challenges
Sterility must be assured for all biologic drug products and typically requires use of aseptic manufacturing techniques. Viral vectors...
Read More24 April 2024
Ascend hires Scott Law as COO and continues strengthening foundation
London, United Kingdom, 24 April 2024 – Ascend Advanced Therapies (Ascend), an end-to-end gene therapy development partner, has announced...
Read More9 April 2024
Ascend acquires GMP manufacturing capacity in Alachua, Florida from Beacon Therapeutics
London, United Kingdom, 9 April 2024 – Ascend Advanced Therapies (Ascend), an end-to-end gene therapy development partner, has acquired...
Read More2 April 2024
The Growing Future of Drug Manufacturing
Pharmaceutical Technology April 2024, Volume 48, Issue 4, pp. 14, 16-17. Continuous innovation in the pharmaceutical industry is leading...
Read More1 April 2024
Taking Full Advantage of Service Providers
Outsourcing clinical trial material (CTM) manufacturing allows drug developers to immediately access an experienced team and existing capacity and...
Read More1 April 2024
CPHI Trends in Outsourcing
According to the latest CPhI Online 2024 Global CDMO Trends Forecast, the most successful outsourcing partnerships occur between equals,...
Read More1 March 2024
Proprietary Cell-Line Development for High-Titer AAV Manufacturing
Ahmed Youssef, Senior Manager USP Process Development, spoke with Cynthia Challener, PhD about cell line development for high-titer AAV...
Read More15 February 2024
Ensuring Quality in Contracted Support
Our Vice President of Quality, Iain McGhee, worked with the team at Pharmaceutical Technology to provide a quick overview...
Read More7 February 2024
Ascend partners with industry to drive down gene therapy cost for better patient access
Gene therapy is a game-changer, offering highly effective and potentially curative treatments that can deliver significant long-term savings. These...
Read More13 November 2023
Design of Experiment (DoE) Based Optimization of Full AAV Particle Enrichment Using Stunner® as a High-Throughput Analysis Tool
Unchained Labs invited Ascend to discuss how we use the Stunner to analyze anion exchange (AEX) chromatography as part...
Read More11 September 2023
In The Lab at BADASS with Mo Mandegar
Our team in the Bay Area of California has been in the BADASS Labs since inception. The location has...
Read More20 June 2023
Cell and gene therapy manufacturing: the next generation of startups
In the middle of 2023, Gwendolyn Wu at Biopharma Dive did an overview of the next generation of startups...
Read More